In the present study we carried out an untargeted metabolomic analysis of plasma samples from patients with obesity to investigate changes in the plasma metabolome before and after 12 weeks of treatment with 3 mg of the GLP-1 RA liraglutide. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.